Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 9,830.00
+70.00 (0.72%)
Feb 5, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 53.97 billion as of February 5, 2026. Its market cap has decreased by -34.80% in one year.
Market Cap
53.97B
Enterprise Value
30.22B
Revenue
24.56B
Ranking
n/a
PE Ratio
15.73
Stock Price
9,830.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 53.97B, a decrease of -81.23%. That is a compound annual growth rate of -68.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 53.97B | -0.91% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.20T |
| Celltrion | 44.42T |
| ALTEOGEN | 21.07T |
| ABL Bio | 10.97T |
| ORIENT BIO | 63.67B |
| MYUNGMOON Pharm co.,Ltd | 57.86B |
| EOFLOW | 51.11B |
| METACARE CO. | 51.02B |